Results
1 -
10 of
11Gastric Mucosal Damage by Nonsteroidal Anti-Inflammatory Drugs, Prostanoids and Drugs Pirazolac: less irritant to the gastrointestinal tract than diclofenac, InPharma Transsynovial distribution and protein binding of pirazolac in patients with rheumatoid arthritis, European Journal of Clinical Pharmacology Pirazolac, Clinical Immunotherapeutics Pharmacokinetics of pirazolac u2014 A new anti-inflammatory drug u2014 in human volunteers I. Absorption, disposition, biotransformation and excretion, European Journal of Drug Metabolism and Pharmacokinetics Pharmacokinetics of pirazolac, a new anti-inflammatory drug, in human volunteers III. Steady state plasma levels, European Journal of Drug Metabolism and Pharmacokinetics Pirazolac: dose linearity with plasma concentrations and renal excretion, InPharma Pirazolac: appeared effective in the treatment of active rheumatoid arthritis, InPharma ZK 90 695: A new antiarthritic drug with tissue targeting properties, Agents and Actions Pharmacokinetics of Pirazolac u2013 a New Anti-Inflammatory Drug u2013 in Human Volunteers II. Dose Linearity of Plasma Levels and Excretion, Pharmaceutical Research